Spectral AI, Inc. (MDAI) vs Oncolytics Biotech Inc. (ONCY)
A side-by-side comparison of Spectral AI, Inc. and Oncolytics Biotech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MDAI
Spectral AI, Inc.
$1.68HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
ONCY
Oncolytics Biotech Inc.
$0.60HealthcareDelayed quote: Oct 6, 2026, 12:59 PM EDT
Total return — MDAI vs ONCY
growth of $100 · dividends reinvested · last 5yMDAI -82.6% (-29.5%/yr)ONCY -85.8% (-32.3%/yr)MDAI compounded faster over this window
MDAI ONCY
MDAI vs ONCY: by the numbers
- •ONCY is the larger company ($60M vs $53M market cap).
- •Both run net losses; ONCY's is the smaller (0.00% vs -69.27% net margin).
Metrics side by side
Valuation
| Metric | MDAI | ONCY |
|---|---|---|
| P/S ratio | 3.53 | N/A |
Profitability
| Metric | MDAI | ONCY |
|---|---|---|
| Gross margin | 41.51% | 0.00% |
| Operating margin | -43.78% | 0.00% |
| Net margin | -69.27% | 0.00% |
| ROIC | -353.68% | -1235.48% |
Growth (annualized)
| Metric | MDAI | ONCY |
|---|---|---|
| Total return CAGR (5Y) | -29.57% | -21.00% |
Frequently asked
- How have MDAI and ONCY total returns compared?
- Over the past 5 years, MDAI delivered -29.57% and ONCY delivered -21.00% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.